Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,501.24
(
0.00%
)
US TECH 100
28,298.00
(
-1.71%
)
Dow Jones
50,063.46
(
0.00%
)
Brent Oil
105.75
(
1.50%
)
Bitcoin
80,380.48
(
-0.83%
)
News Focus
News Focus
Post# of 257566
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122982
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Bickema post# 194060

Tuesday, 08/04/2015 1:47:45 PM

Tuesday, August 04, 2015 1:47:45 PM

Post# of 257566

OCRX—…95 enrolled patients [in the STOP-HE trial] must have been seen as a positive number.

I would say it’s neutral rather than positive. OCRX said it had “over 70” patients enrolled as of 5/3/15 (the date of the 1Q15 CC), so the delta to “over 95” enrolled as of yesterday is 25 patients in three months. That’s actually a little slower than the guidance of about 10 patients per month.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today